Brief: A Factory In A Lab Idorsia's Breakthrough Synthetic Glycan Vaccine Platform Validated For The First Time In Humans
30/06/2025 06:02
June 30 (Reuters) - IDORSIA LTD IDIA.S: A FACTORY IN A LAB: IDORSIA'S BREAKTHROUGH SYNTHETIC GLYCAN VACCINE PLATFORM VALIDATED FOR THE FIRST TIME IN HUMANS IDORSIA LTD - CDI ACUTE CARE COSTS ESTIMATED AT $5-6 BILLION ANNUALLY IN US Source text: ID:nGNE1MybVP Further company coverage: IDIA.S (Gdansk Newsroom) (((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600);))